# Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

> **NCT02496065** · PHASE1 · COMPLETED · sponsor: **Blaze Bioscience Inc.** · enrollment: 30 (actual)

## Conditions studied

- Tumors, Breast

## Interventions

- **DRUG:** BLZ-100

## Key facts

- **NCT ID:** NCT02496065
- **Lead sponsor:** Blaze Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496065, "Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02496065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*